Literature DB >> 1430118

Effect of the number of inseminated spermatozoa on subsequent human and mouse embryonic development in vitro.

J C Dumoulin1, M Bras, J A Land, M H Pieters, M E Enginsu, J P Geraedts, J L Evers.   

Abstract

It has been shown, in both human and mouse in-vitro fertilization (IVF), that an excess number of spermatozoa in the insemination medium leads to reduced fertilization rates. In this study, we evaluated human embryonic development after dividing the oocytes of each of 62 IVF attempts into two groups on the basis of insemination with two widely used concentrations (50,000 and 100,000 spermatozoa/ml). The embryonic growth was retarded in the group inseminated with 100,000 spermatozoa/ml: significantly fewer fast developing embryos (4-cell and 5- to 8-cell stages) were found (53.4% in the 100,000/ml group and 65.5% in the 50,000 group; P less than 0.05). In two experimental series, mouse embryonic development was evaluated in the presence of 0, 50,000, 100,000 and 500,000 spermatozoa per ml. In the first series, the spermatozoa were present during 5-20 h after insemination, while in the second series, the spermatozoa were present during the whole culture period of 120 h. The development of mouse embryos was impaired when 500,000/ml spermatozoa were present during the whole culture period. In contrast with human IVF results, the presence of up to 500,000 spermatozoa during the first 20 h after insemination did not have any significant detrimental effect on blastocyst formation in the mouse.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430118     DOI: 10.1093/oxfordjournals.humrep.a137760

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  The effects of brief gamete co-incubation in human in vitro fertilization.

Authors:  S P Lin; R K Lee; J T Su; M H Lin; Y M Hwu
Journal:  J Assist Reprod Genet       Date:  2000-07       Impact factor: 3.412

2.  Semen amyloids participate in spermatozoa selection and clearance.

Authors:  Nadia R Roan; Nathallie Sandi-Monroy; Nargis Kohgadai; Shariq M Usmani; Katherine G Hamil; Jason Neidleman; Mauricio Montano; Ludger Ständker; Annika Röcker; Marielle Cavrois; Jared Rosen; Kara Marson; James F Smith; Christopher D Pilcher; Friedrich Gagsteiger; Olena Sakk; Michael O'Rand; Polina V Lishko; Frank Kirchhoff; Jan Münch; Warner C Greene
Journal:  Elife       Date:  2017-06-27       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.